Kingsview Wealth Management, LLC Gilead Sciences, Inc. Call Options Transaction History

Kingsview Wealth Management, LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 17, 2021	SELL	$63.47 - $69.35 $196,757 - $214,984	-3,100 Reduced 60.78%	2,000 $3,000
Q1 2020 May 11, 2020	BUY	$62.63 - $80.22 $306,887 - $393,078	4,900 Added 2450.0%	5,100 $1,000
Q4 2019 Jan 31, 2020	BUY	$61.62 - $67.78 $12,324 - $13,556	200 New	200 $0
Q4 2018 Jan 29, 2020	SELL	$60.54 - $79.0 $48,432 - $63,200	-800 Closed	0 $0
Q3 2018 Jan 29, 2020	BUY	$71.28 - $78.92 $57,024 - $63,136	800 New	800 $1,000
Q2 2018 Jan 29, 2020	SELL	$64.88 - $75.68 $58,391 - $68,112	-900 Closed	0 $0
Q1 2018 Jan 29, 2020	BUY	$72.84 - $88.8 $65,556 - $79,920	900 New	900 $4,000
Q3 2017 Jan 29, 2020	SELL	$72.11 - $85.47 $93,743 - $111,111	-1,300 Closed	0 $0
Q2 2017 Jan 29, 2020	BUY	N/A	1,000 Added 333.33%	1,300 $3,000
Q1 2017 Jan 29, 2020	BUY	N/A	300	300 $1,000

1,924

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Kingsview Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Kingsview Wealth Management, LLC with notifications on news.